California biotech Replicate Biosciences will receive up to $550 million from Novo Nordisk in an alliance that aims to track down new drugs for obesity and diabetes. The partners will develop new ...

Novo Nordisk has turned to Replicate Bioscience’s RNA drug platform in a lucrative research collaboration, marking the latest effort by the big pharma company to diversify its pipeline in the hope of ...

Novo Nordisk has both internal research and external alliances pursuing new drugs that could shape the next generation of metabolic medicines. The pharmaceutical giant’s latest move is a partnership ...

Replicate Inc., a startup making it easier for software teams to build artificial intelligence applications, today exited stealth mode and announced that it has secured $17.8 million in funding. The ...

Replicate Bioscience and Novo Nordisk collaborate to develop srRNA-based therapies for obesity, type 2 diabetes, and cardiometabolic diseases. Novo Nordisk receives an exclusive worldwide license to ...

Cloudflare (NET) announced it has agreed to acquire Replicate, an AI platform used for developers to deploy and run AI models. This acquisition will accelerate the company’s vision to make Cloudflare ...

Senior biopharma executive with nearly 20 years of strategy, operational and business development experience will help lead Replicate's corporate strategy, partnerships and next chapter of growth SAN ...

Replicate Bioscience has launched with $40 million to develop self-replicating RNA therapies. Replicate has engineered viral RNA to deliver instructions for making proteins, such as antibodies and ...

Acquisition will enable quick and easy deployment of any AI model to millions of Cloudflare users worldwide Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced it has ...